A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis

Arthritis Rheum. Nov-Dec 1974;17(6):923-37. doi: 10.1002/art.1780170602.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Antinuclear / analysis
  • Azathioprine / administration & dosage
  • Azathioprine / therapeutic use*
  • Child
  • Clinical Trials as Topic
  • Complement System Proteins / analysis
  • Creatinine / urine
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use*
  • Drug Evaluation
  • Female
  • Glomerulonephritis / drug therapy*
  • Glomerulonephritis / immunology
  • Humans
  • Immunosuppression*
  • Kidney Function Tests
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / immunology
  • Male
  • Middle Aged
  • Placebos
  • Proteinuria / etiology
  • Time Factors

Substances

  • Antibodies, Antinuclear
  • Placebos
  • Cyclophosphamide
  • Complement System Proteins
  • Creatinine
  • Azathioprine